99 studies found for:    dengue
Show Display Options
Rank Status Study
81 Not yet recruiting Efficacy and Safety of Ivermectin Against Dengue Infection
Condition: Dengue Fever
Interventions: Drug: 2 days Ivermectin;   Drug: 3 days Ivermectin;   Drug: Placebo
82 Completed Activated Recombinant Human Factor VII in Patients With Dengue Haemorrhagic Fever
Conditions: Acquired Bleeding Disorder;   Dengue Haemorrhagic Fever
Interventions: Drug: activated recombinant human factor VII;   Drug: placebo
83 Active, not recruiting Study of a Dengue Vaccine (V180) in Healthy Adults (V180-001)
Condition: Dengue
Interventions: Biological: Low-dose V180 with low-dose ISCOMATRIX™ adjuvant;   Biological: Low-dose V180 with medium-dose ISCOMATRIX™ adjuvant;   Biological: Medium-dose V180 (non-adjuvanted);   Biological: Medium-dose V180 with low-dose ISCOMATRIX™ adjuvant;   Biological: Medium-dose V180 with medium-dose ISCOMATRIX™ adjuvant;   Biological: Medium-dose V180 with Alhydrogel™ adjuvant;   Biological: High-dose V180 (non-adjuvanted);   Biological: High-dose V180 with low-dose ISCOMATRIX™ adjuvant;   Biological: High-dose V180 with medium-dose ISCOMATRIX™ adjuvant;   Biological: Low-dose V180 with high-dose ISCOMATRIX™ adjuvant;   Biological: Medium-dose V180 with high-dose ISCOMATRIX™ adjuvant;   Biological: High-dose V180 with high-dose ISCOMATRIX™ adjuvant;   Biological: Placebo
84 Unknown  Clinical Evaluation of Insect Repellent and Insecticide Treated Nets in Lao PDR
Conditions: Malaria;   Dengue;   Japanese Encephalitis
Interventions: Drug: 20% deet insect repellent;   Drug: placebo control
85 Recruiting Evaluating the Safety and Immune Response to Two Doses of a Dengue Virus Vaccine Administered 12 Months Apart
Condition: Dengue
Interventions: Biological: TV003 Vaccine;   Biological: Placebo Vaccine
86 Active, not recruiting A Comparison of the Safety and Immunogenicity of Various Schedules of Dengue Vaccine in Healthy Adult Volunteers
Condition: Healthy
Intervention: Biological: DENVax
87 Active, not recruiting Phase 1b Study Investigating Safety & Immunogenicity of DENVax Given Intradermally by Needle or Needle Free PharmaJet Injector
Condition: Normal Healthy Adult
Interventions: Biological: DENVax;   Device: PharmaJet Injector
88 Active, not recruiting Sensitivity Study of Diagnostic for Early Detection of Dengue Infection
Condition: Infectious Diseases
Intervention:
89 Completed Study of HBV-001 D1 in Healthy Adults
Condition: Dengue Fever
Interventions: Biological: DEN1-80E (HBV-001 D1 + 3.5 mg Alhydrogel);   Biological: Placebo for DEN1-80E
90 Completed Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy Adults
Condition: Tick-Borne Encephalitis
Interventions: Biological: LGT(TP21)/DEN4;   Biological: Placebo
91 Completed Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4-3'delta30) in Healthy Adults
Condition: West Nile Fever Encephalitis
Interventions: Biological: WN/DEN4-3'delta30;   Biological: Placebo
92 Completed Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4delta30) in Healthy Adults
Condition: West Nile Fever
Interventions: Biological: WN/DEN4delta30 vaccine;   Biological: Placebo
93 Active, not recruiting Specificity Study of Diagnostic for Early Detection of Dengue Infection
Condition: Infectious Diseases
Intervention:
94 Recruiting The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in Humans
Conditions: Yellow Fever;   Encephalitis, Japanese
Interventions: Biological: Japanese Encephalitis vaccine;   Biological: Yellow Fever vaccine
95 Recruiting Chinese and Western Medicine Treatment of Fever Associated With Bleeding Symptoms
Conditions: Viral Haemorrhagic Fever;   Dengue Fever
Interventions: Drug: Western Medicine;   Drug: TCM and Western Medicine
96 Not yet recruiting Study to Determine the Safety, Tolerability and Pharmacokinetics of UV-4B Solution Administered Orally in Healthy Subjects
Condition: Dengue Fever
Interventions: Drug: UV-4B;   Drug: Placebo
97 Enrolling by invitation Pharmacological Effect of Carica Papaya Leaves Mother Tincture in Healthy Individuals Blood Parameter
Condition: Dengue
Intervention: Drug: Carica folia
98 Active, not recruiting Impact of SQ vs IM Administration of DENVax on Safety and Immunogenicity
Condition: Healthy
Intervention: Biological: DENVax
99 Recruiting Neurodevelopment Outcomes Following Severe Hand Foot and Mouth Disease in Vietnam
Condition: Hand Foot and Mouth Disease
Intervention:

Show previous page of results Previous Page (61-80) Studies Shown (81-99) Next Page
Indicates status has not been verified in more than two years